KINTOR PHARMA-B(09939) completed the issuance of 30.4875 million new shares.

date
21:12 21/11/2025
avatar
GMT Eight
Kangtuo Pharmaceutical-B (09939) announced that all conditions of the agreement have been met, and the agreement has been finalized according to the terms of the agreement...
KINTOR PHARMA-B (09939) announced that all conditions of the agreement have been met, and the agreement was completed on November 21, 2025, in accordance with the terms and conditions of the agreement. The company issued and distributed 30,487,500 new shares to subscribers at a price of HK$1.64 per share on November 21, 2025, in accordance with the terms and conditions of the agreement. The subscribed shares represent approximately 6.11% of the company's enlarged issued share capital after the subscription.